Evidence map›Paper›PMID 28962244›Full record

ArticleToxicology reports2014

Conazole fungicides inhibit Leydig cell testosterone secretion and androgen receptor activation

Maarke J E Roelofs, A Roberto Temming, Aldert H Piersma, Martin van den Berg, Majorie B M van Duursen

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Profiling the endocrine-disrupting properties of triazines, triazoles, and short-chain PFAS.Toxicological sciences : an official journal of the Society of Toxicology · 2024
    Article
  5. Article
  6. Evaluation of a high-throughput H295R homogenous time resolved fluorescence assay for androgen and estrogen steroidogenesis screening.Toxicology in vitro : an international journal published in association with BIBRA · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Maarke J E RoelofsEndocrine Toxicology Research Group, Institute for Risk Assessment Sciences (IRAS), Utrecht University, P.O. Box 80.177, NL-3508 TD Utrecht, The Netherlands.
A Roberto TemmingEndocrine Toxicology Research Group, Institute for Risk Assessment Sciences (IRAS), Utrecht University, P.O. Box 80.177, NL-3508 TD Utrecht, The Netherlands.
Aldert H PiersmaCenter for Health Protection, National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands.
Martin van den BergEndocrine Toxicology Research Group, Institute for Risk Assessment Sciences (IRAS), Utrecht University, P.O. Box 80.177, NL-3508 TD Utrecht, The Netherlands.
Majorie B M van DuursenEndocrine Toxicology Research Group, Institute for Risk Assessment Sciences (IRAS), Utrecht University, P.O. Box 80.177, NL-3508 TD Utrecht, The Netherlands.
Utrecht University · NLNational Institute for Public Health and the Environment · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conazole fungicides are widely used in agriculture despite their suspected endocrine disrupting properties. In this study, the potential (anti-)androgenic effects of ten conazoles were assessed and mutually compared with existing data. Effects of cyproconazole (CYPRO), fluconazole (FLUC), flusilazole (FLUS), hexaconazole (HEXA), myconazole (MYC), penconazole (PEN), prochloraz (PRO), tebuconazole (TEBU), triadimefon (TRIA), and triticonazole (TRIT) were examined using murine Leydig (MA-10) cells and human T47D-ARE cells stably transfected with an androgen responsive element and a firefly luciferase reporter gene. Six conazoles caused a decrease in basal testosterone (T) secretion by MA-10 cells varying from 61% up to 12% compared to vehicle-treated control. T secretion was concentration-dependently inhibited after exposure of MA-10 cells to several concentrations of FLUS (IC

Indexed as

17β-HSD3, 17β-hydroxysteroid dehydrogenase type 33β-HSD1, 3β-hydroxysteroid dehydrogenase type 1Androgen receptor (AR)AR, androgen receptorBMR, benchmark responsecAMP, 8-bromoadenosine 3′,5′-cyclic monophosphateCHO cells, Chinese hamster ovary cellsConazole fungicidesCyp11A1, cytochrome P450 enzyme 11ACyp17, cytochrome P450 enzyme 17CYP19, cytochrome P450 enzyme 19 (aromatase)CYP51, cytochrome P450 enzyme 51/lanosterol 14α-demethylaseCyproconazole (PubChem CID: 86132)CYPRO, cyproconazoleDMEM, Dulbecco's Modified Eagle MediumEC50, half maximal effective concentrationEDCs, endocrine disrupting chemicalsEndocrine disrupting chemicals (EDCs)FLUC, fluconazoleFluconazole (PubChem CID: 3365)FLUS, flusilazoleFlusilazole (PubChem CID: 73675)FLUT, flutamideFP, forward primerFSH(R), follicle-stimulating hormone (receptor)H295R, human adrenocortical carcinoma cellsHexaconazole (PubChem CID: 66461)HEXA, hexaconazoleHMG-CoA red, HMG-CoA reductaseHSD(s), hydroxysteroid dehydrogenase(s)IC50, half maximal inhibitory concentrationLH(R), luteinizing hormone (receptor)MA-10 Leydig cellsMTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromideMyclobutanil (PubChem CID: 6336)MYC, myclobutanilNCBI, National Center for Biotechnology InformationPBS, phosphate-buffered salinePenconazole (PubChem CID: 91693)PEN, penconazolePor, cytochrome P450 oxidoreductaseProchloraz (PubChem CID: 73665)PRO, prochlorazREP, relative effect potencyRIA, radioimmunoassayROS, reactive oxygen speciesRP, reverse primerRT-qPCR, real time quantitative polymerase chain reactionSpermatogenesisStAR, steroidogenic acute regulatory proteinTebuconazole (PubChem CID: 86102)TEBU, tebuconazoleTestosterone (T)Triadimefon (PubChem CID: 39385)TRIA, triadimefonTriticonazole (PubChem CID: 6537961)TRIT, triticonazoleT, testosterone

Identifiers

PMID28962244
PMCPMC5598417
OpenAlexW2133556122

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.